Active targeted drug delivery for microbes using nano-carriers

Area of Science:

• Nanotechnology and Drug Delivery
• Infectious Diseases and Microbiology
• Biomedical Engineering

Background:

• Existing treatments like vaccines and antibiotics face challenges due to microbial resistance and adverse effects.
• Nanocarrier-based drug delivery shows promise but often lacks specificity for infection sites.
• Targeting ligands on nanocarriers ('active targeting') offer a potential solution to improve drug delivery efficiency and safety.

Purpose of the Study:

• To review recent advancements in active targeted nanocarrier strategies for combating infectious diseases.
• To highlight the potential of active targeting to enhance drug delivery to microbial infection sites.
• To discuss the role of active targeting in mitigating toxicity and side effects of antimicrobial therapies.

Main Methods:

• Review of recent scientific literature focusing on active targeted nanocarriers for antimicrobial applications.
• Analysis of studies employing specific targeting ligands on nanocarrier surfaces.
• Introduction of four common nanocarrier types (liposomes, nanoparticles, dendrimers, carbon nanotubes) used in these strategies.

Main Results:

• Active targeting significantly improves the specificity of nanocarrier accumulation at infectious sites.
• Targeted delivery accelerates drug concentration at the infection locus, enhancing antimicrobial efficacy.
• Active targeting strategies demonstrate potential in reducing systemic toxicity and off-target side effects.

Conclusions:

• Active targeted nanocarriers represent a promising frontier in developing more effective and safer antimicrobial therapies.
• Further research into active targeting ligands and nanocarrier systems can overcome current limitations in infectious disease treatment.
• This strategy holds potential for a new paradigm in drug delivery for challenging microbial infections.